Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
---|
06/17/1998 | CN1185209A Assaying protein fragments in body fluids |
06/17/1998 | CN1185176A DNA encoding human paplilloma virus type 18 |
06/17/1998 | CN1185161A (1--3)-beta-d-glucan-binding protein, antidody that recognizes the prolein, and use of the protein and antibody |
06/17/1998 | CN1184817A Method for preparing active immunoglobulin used as oral liquor |
06/16/1998 | US5767372 Chimeric gene comprising dna encoding insecticidal protein fragment, having promoter region and polyadenylation signal allowing dna to be expressed in plant cell |
06/16/1998 | US5767285 Linkers useful for the synthesis of conjugates of methyltrithio antitumor agents |
06/16/1998 | US5767260 A nucleic acid coding for two epitope-containing polypeptide joined by a peptide linker and attached to phospholipase a activating protein or tumor necrosis factor; antiinflammatory agents |
06/16/1998 | US5767249 Monoclonal antibodies against type I phospholipase A2 as a diagnostic and anti-inflammatory therapeutic agent |
06/16/1998 | US5767248 Alzheimers |
06/16/1998 | US5767247 Anti-annexin-V monoclonal antibodies, and preparation and use thereof |
06/16/1998 | US5767246 Human monoclonal antibody specifically binding to surface antigen of cancer cell membrane |
06/16/1998 | US5767243 A complex of human afamin and apolipoprotein a1; a monoclonal antibody specific for human afamin |
06/16/1998 | US5767241 Soluble form of GMP-140 |
06/16/1998 | US5767240 Activity-dependent neurotrophic factor |
06/16/1998 | US5767089 Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules |
06/16/1998 | US5767074 Comprises a soluble c-kit ligand protein and one or more hematopoietic factors selected from interleukins, granulocyte-macrophage-colony stimulating factor, granulocyte-colonyl stimulating factor or erythropoietin |
06/16/1998 | US5767067 Follicle stimulating hormone and pharmaceutical compositions containing same |
06/16/1998 | US5767065 Use of interleukin-4 receptors to inhibit biological responses mediated by interleukin-4 |
06/16/1998 | US5767063 Human IL-8 receptor and antibodies thereto |
06/16/1998 | US5766947 Useful in the diagnosis and therapy of a variety of immune-related diseases |
06/16/1998 | US5766946 Monoclonal antibodies to glycoprotein P |
06/16/1998 | US5766943 DNA sequences for soluble form of CD23 |
06/16/1998 | US5766923 Isolated nucleic acid encoding ligands for FGFR |
06/16/1998 | US5766920 Therapy for cancer, infections, aids and immune deficiency diseases |
06/16/1998 | US5766917 Method for identifying and producing a protease capable of cleaving the TNF receptor |
06/16/1998 | US5766905 Cytoplasmic bacteriophage display system |
06/16/1998 | US5766902 Transfection process |
06/16/1998 | US5766886 Modified antibody variable domains |
06/16/1998 | US5766880 Lung cancer |
06/16/1998 | US5766867 Non-A, non-B hepatitis related nucleic acids, proteins, peptides, antigens, and antibodies |
06/16/1998 | US5766866 Lymphocyte chemoattractant factor and uses thereof |
06/16/1998 | US5766863 Kinase receptor activation assay |
06/16/1998 | US5766856 Diagnostic method for evaluating advanced glycosylation endproducts using MAC-2 receptor |
06/16/1998 | US5766850 Human β2 integrin α subunit |
06/16/1998 | US5766848 Methods for identifying compounds which specifically bind a human betaine/GABA transporter |
06/16/1998 | US5766846 Methods of screening for compounds which inhibit soluble β-amyloid peptide production |
06/16/1998 | US5766845 Immunoreactive polypeptide compositions |
06/16/1998 | US5766844 Human T-cell line infected with HIV-2 which secretes functionally intact HIV-2 GP160. |
06/16/1998 | US5766838 Manual quantitating the number of leukocyte binding tissue cell over a defind are of tissue sample section |
06/16/1998 | US5766609 Administering to the animal to reduce protease activity of fleas feeding on said animal; antifertility agents; veterinary medicine |
06/16/1998 | US5766606 Genetic manipulation of gene encoding a group b streptococcus surface protein so that it is no longer able to bind to human iga |
06/16/1998 | US5766593 Anti-inflammatory CD14 peptides |
06/16/1998 | US5766591 Methods and compositions useful for inhibition of angiogenesis |
06/16/1998 | US5766590 Therapeutic methods and pharmaceutical compositions |
06/16/1998 | US5766588 Tumor immunotherapy using anti-idiotypic antibodies |
06/16/1998 | US5766581 Increasing platelet number with polypeptide molecules attached to polyethylene glycol |
06/16/1998 | US5766570 Lymphocyte activation antigens and antibodies thereto |
06/11/1998 | WO1998025145A1 Improvements in or relating to screening for papilloma viruses |
06/11/1998 | WO1998025142A1 Alarm related peptides and nucleic acids and diagnosis using them |
06/11/1998 | WO1998025125A2 Predisposition to breast cancer by mutations at the ataxia-telangiectasia genetic locus |
06/11/1998 | WO1998024914A1 Nucleotide sequence coding for a flavin-containing monooxygenase, corresponding protein and their applications in the fields of diagnosis and therapy |
06/11/1998 | WO1998024908A1 Human chemokine beta-13 |
06/11/1998 | WO1998024906A2 Isolated mammalian monocyte cell genes; related reagents |
06/11/1998 | WO1998024902A1 Adaptor protein frs2 and related products and methods |
06/11/1998 | WO1998024900A1 Human g-protein receptor hcegh45, a pacap-like (g-protein pituitary adenylate cyclase activating polypeptide-like) receptor |
06/11/1998 | WO1998024898A2 Therapeutic composition comprising the kal protein and use of the kal protein |
06/11/1998 | WO1998024897A1 Junctional adhesion molecule (jam), a transmembrane protein of tight junctions |
06/11/1998 | WO1998024894A2 Pkd1 fragments with bonding areas for pkd1-specific antibodies |
06/11/1998 | WO1998024893A2 TRANSGENIC MAMMALS HAVING HUMAN IG LOCI INCLUDING PLURAL VH AND Vλ REGIONS AND ANTIBODIES PRODUCED THEREFROM |
06/11/1998 | WO1998024888A2 Polypeptides encoded by a human lipase-like gene, compositions and methods |
06/11/1998 | WO1998024887A2 Parasitic nematode transglutaminase proteins, nucleic acid molecules, and uses thereof |
06/11/1998 | WO1998024885A1 Helicobacter pylori antigen having an apparent molecular weight of 16±2 kda, a specific antibody, and its use for the detection of said antigen |
06/11/1998 | WO1998024884A1 Transgenic non-human animals capable of producing heterologous antibodies |
06/11/1998 | WO1998024819A1 5-hydroxytryptophol (5-htol) derivatives, antibodies, immunoassays and detection of recent alcohol consumption |
06/11/1998 | WO1998024818A1 Novel trh receptor |
06/11/1998 | WO1998024817A1 Novel dna, novel protein, and novel antibody |
06/11/1998 | WO1998024810A2 Vertebrate homologues of unc-53 protein of c. elegans |
06/11/1998 | WO1998024808A2 INHIBITION OF IgE-MEDIATED ALLERGIES BY A HUMAN IgE-DERIVED OLIGOPEPTIDE |
06/11/1998 | WO1998012910A3 Novel CREBa isoform |
06/11/1998 | CA2722378A1 Human antibodies that bind tnf alpha |
06/11/1998 | CA2277580A1 Human chemokine beta-13 |
06/11/1998 | CA2274316A1 Therapeutic composition comprising the kal protein and use of the kal protein for the treatment of retinal, renal, neuronal and neural injury |
06/11/1998 | CA2274309A1 Novel dna, novel protein, and novel antibody |
06/11/1998 | CA2274305A1 Novel trh receptor |
06/11/1998 | CA2274145A1 Adaptor protein frs2 and related products and methods |
06/11/1998 | CA2274105A1 Transgenic non-human animals capable of producing heterologous antibodies |
06/11/1998 | CA2274011A1 Nucleotide sequence coding for a flavin-containing monooxygenase, corresponding protein and their applications in the fields of diagnosis and therapy |
06/11/1998 | CA2273827A1 Vertebrate homologues of unc-53 protein of c. elegans |
06/11/1998 | CA2273202A1 Junctional adhesion molecule (jam), a transmembrane protein of tight junctions |
06/11/1998 | CA2273198A1 Human g-protein receptor hcegh45, a pacap-like (g-protein pituitary adenylate cyclase activating polypeptide-like) receptor |
06/11/1998 | CA2273184A1 Alarm related peptides and nucleic acids and diagnosis using them |
06/11/1998 | CA2273051A1 Predisposition to breast cancer by mutations at the ataxia-telangiectasia genetic locus |
06/11/1998 | CA2272848A1 Parasitic nematode transglutaminase proteins, nucleic acid molecules, and uses thereof |
06/11/1998 | CA2224334A1 Self-enhancing, pharmacologically controllable expression systems |
06/11/1998 | CA2224131A1 Novel human 11 cb splice variant |
06/10/1998 | EP0846772A1 Multifunctional ligand system for cell-specific transfer of nucleic acid |
06/10/1998 | EP0846767A2 FtsL - A membrane bound protein from Streptococcus pneumoniae |
06/10/1998 | EP0846766A2 IgA Fc binding protein from Streptococcus pneumoniae |
06/10/1998 | EP0846764A2 Glial cell line-derived neurotrophic factor alpha receptor family |
06/10/1998 | EP0846763A2 A protein phosphatase 1 binding protein, R5 |
06/10/1998 | EP0846762A2 Novel V31 seven transmembrane receptors |
06/10/1998 | EP0846761A1 A novel transcription factor expressed in cycling cells, nucleic acid molecules encoding said transcription factor and its promoter region and uses thereof |
06/10/1998 | EP0846760A1 Production and use of anthelmintic agents and protective immunogens |
06/10/1998 | EP0846700A1 Pollen Allergens |
06/10/1998 | EP0846266A1 Differential assay for ulcerative colitis, primary sclerosing cholangitis and type 1 autoimmune hepatitis |
06/10/1998 | EP0846183A2 High efficiency retroviral packaging system |
06/10/1998 | EP0846178A1 Allergen-xcd32 fusion proteins |
06/10/1998 | EP0846173A1 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
06/10/1998 | EP0846169A1 MONOCLONAL ANTIBODIES AGAINST SOLUBLE TNF-ALPHA RECEPTORS p55 and p75 AS WELL AS AGAINST TNF-ALPHA AND ITS ANALOGUES |
06/10/1998 | EP0846165A1 Novel filariid nematode cysteine protease proteins, nucleic acid molecules and uses thereof |